Maya Chilbert (Holsen) (@MayaHolsen) profile picture

Clinical Assistant Professor University at Buffalo School of Pharmacy • Cardiac ICU Pharmacist Buffalo General • BCCP

Buffalo, NY
Joined January 2018
Photo by Maya Chilbert (Holsen) (@MayaHolsen)Photo by Maya Chilbert (Holsen) (@MayaHolsen)Photo by Maya Chilbert (Holsen) (@MayaHolsen)Photo by Maya Chilbert (Holsen) (@MayaHolsen)Photo by Maya Chilbert (Holsen) (@MayaHolsen)Photo by Maya Chilbert (Holsen) (@MayaHolsen)Photo by Maya Chilbert (Holsen) (@MayaHolsen)Photo by Maya Chilbert (Holsen) (@MayaHolsen)Photo by Maya Chilbert (Holsen) (@MayaHolsen)Photo by Maya Chilbert (Holsen) (@MayaHolsen)
Maya Chilbert (Holsen) retweeted
We hope everyone can join a webinar with @VCUDPOSChair, Kate Cabral, @nishantshahmd and Dr. Larry Sperling to discuss trials from AHA including SELECT, ESPRIT, and VERVE-1 TOMORROW Thursday January 18th from 3-4 PM! unc.zoom.us/j/95388169426
1
4
6
1,627
Maya Chilbert (Holsen) retweeted
Listen to your heart ❤ 🎵 What to do when a patient doesn't make it to PCI in 2 hours. Don't miss this #TeachingTuesday review of thrombolytics by @LyndsiRoland and her mentor Rachel Klosko
19
1
61
6,121
Maya Chilbert (Holsen) retweeted
To treat ventricular tachycardia (VT) acutely treatment options can include lidocaine and amiodarone. Lidocaine is lipophilic and can cross the blood brain barrier. Amiodarone causes iodine deposits that can be of concern when used chronically. @MayaHolsen #OTILTW
1
1
271
Maya Chilbert (Holsen) retweeted
Hypervolemic hyponatremia can occur due to SIADH. The usual treatment includes fluid restriction, IV furosemide, and 3% NS. If the serum sodium is less than 125 use of vasopressin antagonists can be considered such as Tolvaptan and Conivaptan. @MayaHolsen #OTILTW
1
1
271
Maya Chilbert (Holsen) retweeted
Switching between P2Y12 inhibitors is common when considering patient cost, compliance, and optimizing outcomes. Changing Brillinta to Plavix acutely requires reloading Plavix 600 mg x 1 (24h after last dose) and then continuing a maintenance dose of 75 mg QD #OTILT @MayaHolsen
1
3
238
Maya Chilbert (Holsen) retweeted
For patients with heart block (HB) medications that may be causing it should be removed (BB, CCB, digoxin, etc.) If the HB is irreversible a pacemaker (PM) may need to be placed in the patient and heparin should be held 24 hrs before + 48 hrs after PM placement @MayaHolsen #OTILT
2
3
231
Maya Chilbert (Holsen) retweeted
Did you know that heart block (also known as atrioventricular block) may be caused by common medications. These include: beta blockers, calcium channel blockers, anesthetics, and digoxin. It is important as pharmacists to recognize these medications for discontinuation. #OTILT
1
2
277
Maya Chilbert (Holsen) retweeted
A serum potassium goal in a cardiac unit is 4 mEq/L. When repleting potassium each 10 mEq we give a patient will increase their serum potassium by 0.1 mEq. It is better to use oral potassium when possible because IV potassium is caustic and can be painful #OTILT
1
5
221
Maya Chilbert (Holsen) retweeted
Diuretics will only deplete your intravascular volume. When patients are fluid overloaded the extra fluid is in their extravascular space. Thus we can only diuresis patients so quickly because the fluid needs to move intravascularly #OTILT
1
2
223
Maya Chilbert (Holsen) retweeted
Proud moment when a project we've spent countless hours developing comes to fruition. Take our interprofessional CE program to improve your ability to care for patients with kidney disease!
Our new curriculum is LIVE. 🎉 If you want to learn more about Slowing Kidney Disease Progression, enroll at the link in our bio. #TwitteRX #pharmacists #AKHOMM #NephTwitter #kidneycare #PharmacyUMN #GetTheMedicationRight #nephrologist #nephrologynurse #nursepractitioner
2
10
740
Maya Chilbert (Holsen) retweeted
Are you a pharmacy student interested in creating a mentored Teaching Tuesday post? We have 5 additional spots available! Fill out our survey by May 3 to let us know you are interested! forms.gle/2gossVwGXxcjob7N9 Professors please share with your students!
4
1
4
1,925
Maya Chilbert (Holsen) retweeted
Reminder to join us tomorrow to review CLEAR Outcomes and LODESTAR trials!
Join us for the next Cards PRN JC on April 25th @ 3PM EST. We’ll be discussing lipid-lowering therapies w/ PGY2 CV residents Dr. Ami Patel and Dr. Aaron Adkisson as they review CLEAR Outcomes and LODESTAR Trials! teams.microsoft.com/l/meetup…
4
13
4,319
Maya Chilbert (Holsen) retweeted
It was such an honor to represent @UB_SPPS at the NYSCHP Annual Assembly student quiz bowl with my pharmacy knowledge buddy Aman Patel! Happy to come away with second place against some excellent competition. Need to brush up on meningitis treatment guidelines before APPEs 😬
1
1
7
475
Had a blast talking about the benefits of professional social media at Annual Assembly! @NYSCHP @UBPharm #TwitteRx
19
962
Awesome UB students presenting their research at @NYSCHP @UBPharm 💊🎉
1
8
390
You’re telling me Fomepizole Aripiprazole Omeprazole And Ketoconazole ALL DO DIFFERENT THINGS? AND I HAVE TO KNOW THE DIFFERENCE?
55
274
98
1,882
203,371
Is anyone else worried about cardiogenic shock when initiating a BB after ACS? Our study found low rates after PCI, even in those with anterior MI! Watch for elevated troponin as a potential risk factor for shock development. So proud of @llacours23 for her hard work! @UBPharm
Early initiation of a beta-blocker in patients with STEMI and PCI with risk factors for cardiogenic shock does not appear to be associated with shock in most patients pubmed.ncbi.nlm.nih.gov/3682… @mayachilbert @llacourse23 @UBPharm #pharmacology #medicine #cardiovascular #troponin
1
3
17
2,585
So proud of all of our residents and students showcasing their research! @llacours23 @OliviaaDenny @Chelsea_barvian
This Post is from an account that no longer exists. Learn more
1
3
657
#MRAs for the win! Though they can have serious side effects, when used appropriately with monitoring can improve care for many patients with HF! 🫀
A review of the rationale for the use of mineralocorticoid receptor antagonists (MRA) in heart failure and a summary of the clinical trial evidence for MRA in HFmrEF/HFpEF. buff.ly/3MIF1Ru @accpcardprn @orlyvardeny
1
6
2,394